PAT4 levels control amino-acid sensitivity of rapamycin-resistant mTORC1 from the Golgi and affect clinical outcome in colorectal cancer

Fan S-J., Snell C., Turley H., Li J-L., McCormick R., Perera SMW., Heublein S., Kazi S., Azad A., Wilson C., Harris AL., Goberdhan DCI.

DOI

10.1038/onc.2015.363

Type

Journal article

Journal

Oncogene

Publisher

Springer Science and Business Media LLC

Publication Date

06/2016

Volume

35

Pages

3004 - 3015

Permalink Original publication